Metabolomics
Metabolomics market is segmented by region (country), players, by Type and by Application. Player ... Read More
Global and United States Biotherapeutics Cell Line Development Market Report & Forecast 2023-2028
1 Study Coverage
1.1 Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million) Introduction
1.2 Global Biotherapeutics Cell Line Development Outlook 2017 VS 2022 VS 2028
1.2.1 Global Biotherapeutics Cell Line Development Market Size for the Year 2017-2028
1.2.2 Global Biotherapeutics Cell Line Development Market Size for the Year 2017-2028
1.3 Biotherapeutics Cell Line Development Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Biotherapeutics Cell Line Development in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Biotherapeutics Cell Line Development Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Biotherapeutics Cell Line Development Market Dynamics
1.4.1 Biotherapeutics Cell Line Development Industry Trends
1.4.2 Biotherapeutics Cell Line Development Market Drivers
1.4.3 Biotherapeutics Cell Line Development Market Challenges
1.4.4 Biotherapeutics Cell Line Development Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Biotherapeutics Cell Line Development by Type
2.1 Biotherapeutics Cell Line Development Market Segment by Type
2.1.1 Transfection & Selection
2.1.2 Single Cell Cloning
2.2 Global Biotherapeutics Cell Line Development Market Size by Type (2017, 2022 & 2028)
2.3 Global Biotherapeutics Cell Line Development Market Size by Type (2017-2028)
2.4 United States Biotherapeutics Cell Line Development Market Size by Type (2017, 2022 & 2028)
2.5 United States Biotherapeutics Cell Line Development Market Size by Type (2017-2028)
3 Biotherapeutics Cell Line Development by Application
3.1 Biotherapeutics Cell Line Development Market Segment by Application
3.1.1 In-house
3.1.2 Outsource
3.1.3 Hybrid
3.1.4 Do-It-Yourself (DIY)
3.2 Global Biotherapeutics Cell Line Development Market Size by Application (2017, 2022 & 2028)
3.3 Global Biotherapeutics Cell Line Development Market Size by Application (2017-2028)
3.4 United States Biotherapeutics Cell Line Development Market Size by Application (2017, 2022 & 2028)
3.5 United States Biotherapeutics Cell Line Development Market Size by Application (2017-2028)
4 Global Biotherapeutics Cell Line Development Competitor Landscape by Company
4.1 Global Biotherapeutics Cell Line Development Market Size by Company
4.1.1 Top Global Biotherapeutics Cell Line Development Companies Ranked by Revenue (2021)
4.1.2 Global Biotherapeutics Cell Line Development Revenue by Player (2017-2022)
4.2 Global Biotherapeutics Cell Line Development Concentration Ratio (CR)
4.2.1 Biotherapeutics Cell Line Development Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Biotherapeutics Cell Line Development in 2021
4.2.3 Global Biotherapeutics Cell Line Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Biotherapeutics Cell Line Development Headquarters, Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million) Type
4.3.1 Global Biotherapeutics Cell Line Development Headquarters and Area Served
4.3.2 Global Biotherapeutics Cell Line Development Companies Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Biotherapeutics Cell Line Development Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Biotherapeutics Cell Line Development Market Size by Company
4.5.1 Top Biotherapeutics Cell Line Development Players in United States, Ranked by Revenue (2021)
4.5.2 United States Biotherapeutics Cell Line Development Revenue by Players (2020, 2021 & 2022)
5 Global Biotherapeutics Cell Line Development Market Size by Region
5.1 Global Biotherapeutics Cell Line Development Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Biotherapeutics Cell Line Development Market Size by Region (2017-2028)
5.2.1 Global Biotherapeutics Cell Line Development Market Size by Region: 2017-2022
5.2.2 Global Biotherapeutics Cell Line Development Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Biotherapeutics Cell Line Development Market Size YoY Growth 2017-2028
6.1.2 North America Biotherapeutics Cell Line Development Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Biotherapeutics Cell Line Development Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Biotherapeutics Cell Line Development Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Biotherapeutics Cell Line Development Market Size YoY Growth 2017-2028
6.3.2 Europe Biotherapeutics Cell Line Development Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Biotherapeutics Cell Line Development Market Size YoY Growth 2017-2028
6.4.2 Latin America Biotherapeutics Cell Line Development Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Biotherapeutics Cell Line Development Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Biotherapeutics Cell Line Development Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Becton Dickinson & Company
7.1.1 Becton Dickinson & Company Company Details
7.1.2 Becton Dickinson & Company Business Overview
7.1.3 Becton Dickinson & Company Biotherapeutics Cell Line Development Introduction
7.1.4 Becton Dickinson & Company Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.1.5 Becton Dickinson & Company Recent Development
7.2 Beckman Coulter
7.2.1 Beckman Coulter Company Details
7.2.2 Beckman Coulter Business Overview
7.2.3 Beckman Coulter Biotherapeutics Cell Line Development Introduction
7.2.4 Beckman Coulter Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.2.5 Beckman Coulter Recent Development
7.3 Boehringer Ingelheim Group
7.3.1 Boehringer Ingelheim Group Company Details
7.3.2 Boehringer Ingelheim Group Business Overview
7.3.3 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Introduction
7.3.4 Boehringer Ingelheim Group Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.3.5 Boehringer Ingelheim Group Recent Development
7.4 Catalent Inc.
7.4.1 Catalent Inc. Company Details
7.4.2 Catalent Inc. Business Overview
7.4.3 Catalent Inc. Biotherapeutics Cell Line Development Introduction
7.4.4 Catalent Inc. Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.4.5 Catalent Inc. Recent Development
7.5 CMC Biologics A/S
7.5.1 CMC Biologics A/S Company Details
7.5.2 CMC Biologics A/S Business Overview
7.5.3 CMC Biologics A/S Biotherapeutics Cell Line Development Introduction
7.5.4 CMC Biologics A/S Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.5.5 CMC Biologics A/S Recent Development
7.6 Lonza Group Ltd.
7.6.1 Lonza Group Ltd. Company Details
7.6.2 Lonza Group Ltd. Business Overview
7.6.3 Lonza Group Ltd. Biotherapeutics Cell Line Development Introduction
7.6.4 Lonza Group Ltd. Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.6.5 Lonza Group Ltd. Recent Development
7.7 EMD Millipore
7.7.1 EMD Millipore Company Details
7.7.2 EMD Millipore Business Overview
7.7.3 EMD Millipore Biotherapeutics Cell Line Development Introduction
7.7.4 EMD Millipore Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.7.5 EMD Millipore Recent Development
7.8 Partec (Sysmex Corporation)
7.8.1 Partec (Sysmex Corporation) Company Details
7.8.2 Partec (Sysmex Corporation) Business Overview
7.8.3 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Introduction
7.8.4 Partec (Sysmex Corporation) Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.8.5 Partec (Sysmex Corporation) Recent Development
7.9 ProBioGen AG
7.9.1 ProBioGen AG Company Details
7.9.2 ProBioGen AG Business Overview
7.9.3 ProBioGen AG Biotherapeutics Cell Line Development Introduction
7.9.4 ProBioGen AG Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.9.5 ProBioGen AG Recent Development
7.10 Selexis SA
7.10.1 Selexis SA Company Details
7.10.2 Selexis SA Business Overview
7.10.3 Selexis SA Biotherapeutics Cell Line Development Introduction
7.10.4 Selexis SA Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.10.5 Selexis SA Recent Development
7.11 Sigma-Aldrich Co. LLC.
7.11.1 Sigma-Aldrich Co. LLC. Company Details
7.11.2 Sigma-Aldrich Co. LLC. Business Overview
7.11.3 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Introduction
7.11.4 Sigma-Aldrich Co. LLC. Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.11.5 Sigma-Aldrich Co. LLC. Recent Development
7.12 Sony Biotechnology Inc.
7.12.1 Sony Biotechnology Inc. Company Details
7.12.2 Sony Biotechnology Inc. Business Overview
7.12.3 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Introduction
7.12.4 Sony Biotechnology Inc. Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.12.5 Sony Biotechnology Inc. Recent Development
7.13 Thermo Fisher Scientific Inc.
7.13.1 Thermo Fisher Scientific Inc. Company Details
7.13.2 Thermo Fisher Scientific Inc. Business Overview
7.13.3 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Introduction
7.13.4 Thermo Fisher Scientific Inc. Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
7.13.5 Thermo Fisher Scientific Inc. Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Biotherapeutics Cell Line Development Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Biotherapeutics Cell Line Development Market Trends
Table 3. Biotherapeutics Cell Line Development Market Drivers
Table 4. Biotherapeutics Cell Line Development Market Challenges
Table 5. Biotherapeutics Cell Line Development Market Restraints
Table 6. Global Biotherapeutics Cell Line Development Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Biotherapeutics Cell Line Development Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Biotherapeutics Cell Line Development Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Biotherapeutics Cell Line Development Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Biotherapeutics Cell Line Development Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Biotherapeutics Cell Line Development Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Biotherapeutics Cell Line Development Revenue Share by Player, 2017-2022
Table 13. Global Biotherapeutics Cell Line Development Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biotherapeutics Cell Line Development by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotherapeutics Cell Line Development as of 2021)
Table 15. Top Players of Biotherapeutics Cell Line Development in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Biotherapeutics Cell Line Development Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Biotherapeutics Cell Line Development Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Biotherapeutics Cell Line Development Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Biotherapeutics Cell Line Development Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Biotherapeutics Cell Line Development Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Biotherapeutics Cell Line Development Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Biotherapeutics Cell Line Development Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Biotherapeutics Cell Line Development Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Biotherapeutics Cell Line Development Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Biotherapeutics Cell Line Development Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Biotherapeutics Cell Line Development Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Biotherapeutics Cell Line Development Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Becton Dickinson & Company Company Details
Table 31. Becton Dickinson & Company Business Overview
Table 32. Becton Dickinson & Company Biotherapeutics Cell Line Development Product
Table 33. Becton Dickinson & Company Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 34. Becton Dickinson & Company Recent Development
Table 35. Beckman Coulter Company Details
Table 36. Beckman Coulter Business Overview
Table 37. Beckman Coulter Biotherapeutics Cell Line Development Product
Table 38. Beckman Coulter Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 39. Beckman Coulter Recent Development
Table 40. Boehringer Ingelheim Group Company Details
Table 41. Boehringer Ingelheim Group Business Overview
Table 42. Boehringer Ingelheim Group Biotherapeutics Cell Line Development Product
Table 43. Boehringer Ingelheim Group Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 44. Boehringer Ingelheim Group Recent Development
Table 45. Catalent Inc. Company Details
Table 46. Catalent Inc. Business Overview
Table 47. Catalent Inc. Biotherapeutics Cell Line Development Product
Table 48. Catalent Inc. Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 49. Catalent Inc. Recent Development
Table 50. CMC Biologics A/S Company Details
Table 51. CMC Biologics A/S Business Overview
Table 52. CMC Biologics A/S Biotherapeutics Cell Line Development Product
Table 53. CMC Biologics A/S Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 54. CMC Biologics A/S Recent Development
Table 55. Lonza Group Ltd. Company Details
Table 56. Lonza Group Ltd. Business Overview
Table 57. Lonza Group Ltd. Biotherapeutics Cell Line Development Product
Table 58. Lonza Group Ltd. Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 59. Lonza Group Ltd. Recent Development
Table 60. EMD Millipore Company Details
Table 61. EMD Millipore Business Overview
Table 62. EMD Millipore Biotherapeutics Cell Line Development Product
Table 63. EMD Millipore Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 64. EMD Millipore Recent Development
Table 65. Partec (Sysmex Corporation) Company Details
Table 66. Partec (Sysmex Corporation) Business Overview
Table 67. Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Product
Table 68. Partec (Sysmex Corporation) Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 69. Partec (Sysmex Corporation) Recent Development
Table 70. ProBioGen AG Company Details
Table 71. ProBioGen AG Business Overview
Table 72. ProBioGen AG Biotherapeutics Cell Line Development Product
Table 73. ProBioGen AG Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 74. ProBioGen AG Recent Development
Table 75. Selexis SA Company Details
Table 76. Selexis SA Business Overview
Table 77. Selexis SA Biotherapeutics Cell Line Development Product
Table 78. Selexis SA Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 79. Selexis SA Recent Development
Table 80. Sigma-Aldrich Co. LLC. Company Details
Table 81. Sigma-Aldrich Co. LLC. Business Overview
Table 82. Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Product
Table 83. Sigma-Aldrich Co. LLC. Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 84. Sigma-Aldrich Co. LLC. Recent Development
Table 85. Sony Biotechnology Inc. Company Details
Table 86. Sony Biotechnology Inc. Business Overview
Table 87. Sony Biotechnology Inc. Biotherapeutics Cell Line Development Product
Table 88. Sony Biotechnology Inc. Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 89. Sony Biotechnology Inc. Recent Development
Table 90. Thermo Fisher Scientific Inc. Company Details
Table 91. Thermo Fisher Scientific Inc. Business Overview
Table 92. Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Product
Table 93. Thermo Fisher Scientific Inc. Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 94. Thermo Fisher Scientific Inc. Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Biotherapeutics Cell Line Development Product Picture
Figure 2. Global Biotherapeutics Cell Line Development Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Biotherapeutics Cell Line Development Market Size 2017-2028 (US$ Million)
Figure 4. United States Biotherapeutics Cell Line Development Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Biotherapeutics Cell Line Development Market Size 2017-2028 (US$ Million)
Figure 6. United States Biotherapeutics Cell Line Development Market Share in Global 2017-2028
Figure 7. Biotherapeutics Cell Line Development Report Years Considered
Figure 8. Product Picture of Transfection & Selection
Figure 9. Product Picture of Single Cell Cloning
Figure 10. Global Biotherapeutics Cell Line Development Market Share by Type in 2022 & 2028
Figure 11. Global Biotherapeutics Cell Line Development Market Size by Type (2017-2028) & (US$ Million)
Figure 12. Global Biotherapeutics Cell Line Development Market Share by Type (2017-2028)
Figure 13. United States Biotherapeutics Cell Line Development Market Share by Type in 2022 & 2028
Figure 14. United States Biotherapeutics Cell Line Development Market Size by Type (2017-2028) & (US$ Million)
Figure 15. United States Biotherapeutics Cell Line Development Market Share by Type (2017-2028)
Figure 16. Product Picture of In-house
Figure 17. Product Picture of Outsource
Figure 18. Product Picture of Hybrid
Figure 19. Product Picture of Do-It-Yourself (DIY)
Figure 20. Global Biotherapeutics Cell Line Development Market Share by Application in 2022 & 2028
Figure 21. Global Biotherapeutics Cell Line Development Market Size by Application (2017-2028) & (US$ Million)
Figure 22. Global Biotherapeutics Cell Line Development Market Share by Application (2017-2028)
Figure 23. United States Biotherapeutics Cell Line Development Market Share by Application in 2022 & 2028
Figure 24. United States Biotherapeutics Cell Line Development Market Size by Application (2017-2028) & (US$ Million)
Figure 25. United States Biotherapeutics Cell Line Development Market Share by Application (2017-2028)
Figure 26. North America Biotherapeutics Cell Line Development Market Size Growth Rate 2017-2028 (US$ Million)
Figure 27. U.S. Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Canada Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Europe Biotherapeutics Cell Line Development Market Size Growth Rate 2017-2028 (US$ Million)
Figure 30. Germany Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. France Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. U.K. Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Italy Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Russia Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Biotherapeutics Cell Line Development Market Size Growth Rate 2017-2028 (US$ Million)
Figure 36. China Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Japan Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. South Korea Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. India Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Australia Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Taiwan Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Indonesia Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Thailand Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Malaysia Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Philippines Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Latin America Biotherapeutics Cell Line Development Market Size Growth Rate 2017-2028 (US$ Million)
Figure 47. Mexico Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Brazil Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Argentina Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Biotherapeutics Cell Line Development Market Size Growth Rate 2017-2028 (US$ Million)
Figure 51. Turkey Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. U.A.E Biotherapeutics Cell Line Development Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Becton Dickinson & Company Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 55. Beckman Coulter Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 56. Boehringer Ingelheim Group Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 57. Catalent Inc. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 58. CMC Biologics A/S Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 59. Lonza Group Ltd. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 60. EMD Millipore Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 61. Partec (Sysmex Corporation) Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 62. ProBioGen AG Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 63. Selexis SA Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 64. Sigma-Aldrich Co. LLC. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 65. Sony Biotechnology Inc. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 66. Thermo Fisher Scientific Inc. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Becton Dickinson & Company Beckman Coulter Boehringer Ingelheim Group Catalent Inc. CMC Biologics A/S Lonza Group Ltd. EMD Millipore Partec (Sysmex Corporation) ProBioGen AG Selexis SA Sigma-Aldrich Co. LLC. Sony Biotechnology Inc. Thermo Fisher Scientific Inc.